Q9UBZ9 (REV1_HUMAN) Homo sapiens (Human)
DNA repair protein REV1 UniProtKBInterProSTRINGInteractive Modelling
It is possible new templates exist for this target since these models were created.
Available Structures
16 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Solution NMR structure of human Rev1 (932-1039) in complex with ubiquitin |
Heteromer P0CG47; | 100 | ||||
| Structure of polymerase-interacting domain of human Rev1 in complex with translesional synthesis po… |
Heteromer O60673; Q9UI95; | 100 | ||||
| Crystal structure of human Rev3-Rev7-Rev1 complex |
Heteromer O60673; Q9UI95; | 100 | ||||
| Crystal structure of human Rev3-Rev7-Rev1-Polkappa complex |
Heteromer O60673; Q9UBT6; Q9UI95; | 100 | ||||
| Solution structure of polymerase-interacting domain of human Rev1 in complex with translesional syn… |
Heteromer Q9UBT6; | 100 | ||||
| Rational drug design of phenazopyridine derivatives as novel inhibitors of Rev1-CT |
Heteromer O60673; Q9UI95; | 100 | 1×U8M; | |||
| Crystal structure of REV1-REV7-REV3 ternary complex |
Heteromer O60673; Q9UI95; | 100 | ||||
| Structure of C-terminal domain of human polymerase Rev1 in complex with PolD3 RIR-motif |
Heteromer Q15054; | 100 | ||||
| C-terminal domain of human REV1 in complex with DNA-polymerase H (eta) |
Heteromer Q9Y253; | 100 | ||||
| Rational drug design of phenazopyridine derivatives as novel inhibitors of Rev1-CT |
Heteromer O60673; Q9UI95; | 100 | ||||
| REV1 UBM2 domain complex with ubiquitin |
Heteromer P0CG47; | 100 | 3×NI; | |||
| The structural basis for the coordination of Y-family Translesion DNA Polymerases by Rev1 | homo-4-mer | 100 | 5×MG; 6×NI; | |||
| Structure of human Rev1-DNA-dNTP ternary complex | monomer | 100.0 | 1×DCP; 4×MG; | |||
| Structure of the C-terminal domain from human REV1 | monomer | 100 | ||||
| Solution structure of the BRCT domain from human DNA repair protein REV1 | monomer | 100 | ||||
| Structures of REV1 UBM2 domain complex with ubiquitin and with the first small-molecule that inhibi… | monomer | 100 | ||||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3gqc.1.A | monomer | 0.83 | 1×MG; | 100.00 | ||
| 1t94.2.A | monomer | 0.63 | 30.23 | |||
| 8tlt.1.F | monomer | 0.61 | 27.85 | |||
| 1t94.1.A | monomer | 0.61 | 30.23 | |||
4 SWISS-MODEL models built on isoform sequence
| Isoform | Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|---|
| Isoform 2 | 3gqc.1.A | monomer | 0.82 | 1×MG; | 100.00 | ||
| Isoform 2 | 8tlt.1.F | monomer | 0.61 | 27.85 | |||
| Isoform 3 | 8tlq.1.F | monomer | 0.67 | 39.52 | |||
| Isoform 3 | 3gqc.1.A | monomer | 0.66 | 100.00 | |||